Uracil/tegafur as a possible salvage therapy in chemo-refractory colorectal cancer patients: a single institutional retrospective study

Bayoglu, Ibrahim; Yildiz, İbrahim; Varol, Umut; Cokmert, Suna; Alacacioglu, Ahmet; Kucukzeybek, Yuksel; Akyol, Murat; Demir, Lutfiye; Dirican, Ahmet; Tarhan, Oktay

doi:10.5114/wo.2015.53374

Uracil/tegafur as a possible salvage therapy in chemo-refractory colorectal cancer patients: a single institutional retrospective study

Atıf İçin Kopyala

Bayoglu I. V. , Yildiz İ. , Varol U., Cokmert S., Alacacioglu A., Kucukzeybek Y., et al.

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, cilt.19, ss.385-390, 2015 (ESCI İndekslerine Giren Dergi)

Cilt numarası: 19 Konu: 5
Basım Tarihi: 2015
Doi Numarası: 10.5114/wo.2015.53374
Dergi Adı: WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY
Sayfa Sayısı: ss.385-390

Özet

Aim of the study: Our aim was to determine the activity and toxicity of uracil/tegafur and leucovorin combination in metastatic colorectal cancer (mCRC) patients who have progressed with all currently active agents.